Finance

Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
US$ ४.०३
-१.७१%
(-०.०७०) 1D
अक्टोबर १५, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
US$ ३.९५
High
US$ ४.१५
Low
US$ ३.९१
Mkt. cap
१.९४ करोड
Avg. vol.
७८.६१ हजार
Volume
२३.९३ हजार
52-wk high
US$ २३.५०
52-wk low
US$ ३.२५
EPS
-US$ ४२३.७३
Beta
१.५६
Shares outstanding
४८.०४ लाख
No. of employees
५
Open
US$ ३.९५
High
US$ ४.१५
Low
US$ ३.९१
Mkt. cap
१.९४ करोड
Avg. vol.
७८.६१ हजार
Volume
२३.९३ हजार
52-wk high
US$ २३.५०
52-wk low
US$ ३.२५
EPS
-US$ ४२३.७३
Beta
१.५६
Shares outstanding
४८.०४ लाख
No. of employees
५
News stories
From web sources and news partners
TipRanks
TipRanks
·
१ दिन पहिले
Quoin Pharmaceuticals Gains EMA Orphan Status for QRX003
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees५
Founded१९८६
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current US$ ४.०३
US$ ३५.०० (+७६८.४९%)
Average
US$ २२.२५ (+४५२.११%)
Lowest
US$ १४.०० (+२४७.३९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
US$ १४.००
+२४७.४%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
US$ २०.००
+३९६.३%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
US$ २०.००
+३९६.३%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
US$ ३५.००
+७६८.५%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
US$ १२.००
+१९७.८%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
US$ ३०.००
+६४४.४%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२२.८१ लाख
३०.९७ लाख
३४.३४ लाख
३६.२७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१७.३९ लाख
१४.२४ लाख
१६.९७ लाख
१८.४६ लाख
Operating expense
४०.२० लाख
४५.२० लाख
५१.३१ लाख
५४.७४ लाख
Total operating expenses
४०.२० लाख
४५.२० लाख
५१.३१ लाख
५४.७४ लाख
Operating income
-४०.२० लाख
-४५.२० लाख
-५१.३१ लाख
-५४.७४ लाख
Other non operating income
९.४९ हजार
३६४.००
-१३.३० हजार
१.५८ हजार
EBT including unusual items
-३९.४८ लाख
-४३.४८ लाख
-४९.९८ लाख
-५३.७१ लाख
EBT excluding unusual items
-३९.४८ लाख
-४३.४८ लाख
-४९.९८ लाख
-५३.७१ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३९.४८ लाख
-४३.४८ लाख
-४९.९८ लाख
-५३.७१ लाख
Net profit margin
-
-
-
-
Earnings per share
-६.७०
-
-१.७७
-१.९०
Interest and investment income
६२.२७ हजार
१.७२ लाख
१.४७ लाख
१.०१ लाख
Interest expense
-
-
-
-
Net interest expenses
६२.२७ हजार
१.७२ लाख
१.४७ लाख
१.०१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३९.९५ लाख
-४४.९५ लाख
-५१.०६ लाख
-५४.४९ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू